Pfizer Covid vaccine information

27/03/2021

Do you want to be a blogger? Here’s you chance! Visit: https://www.mygov.in/task/inviting-blogs-mygov-citizens-largest-vaccination-drive/ today!

27/03/2021

COVID-19 Updates as on March 23, 2021 at 8 AM 👇

▪️Active Cases: * 3,45,377 *
▪️Discharged cases: * 1,11,81,253 *
▪️Death cases: * 1,60,166 *

08/03/2021

COVID-19 Updates as on 08 March 2021 at 8 AM

Active Cases: 1,88,747
Discharged cases: 1,08,82,798
Death cases: 1,57,853

* Please follow the appropriate behaviour - 2 Gaz Doori, Mask 😷 Hai Zaroori. *

13/02/2021

13/02/2021

* COVID-19 updates as on 13.02.2021 at 8 AM 👇

▪️ Active Cases: * 1,36,571 *
▪️ Cured/Discharged: * 1,06,00,625 *
▪️ Death cases: * 1,55,550 *

10/02/2021

* Useful Alerts *

❇️ * Over 66 lakh 11 thousand people administered COVID-19 vaccines so far; National recovery rate reaches 97.27% *

❇️ * More than 13 thousand patients recovered in the last 24 hours *

❇️ * Kerala & Maharashtra account for 71% of the total Active Cases of the country *

❇️ * Prime Minister to inaugurate World Sustainable Development Summit-2021 this evening *

❇️ * PM Modi replies to the Motion of Thanks on the President’s address says; *
▪️* President speech showcased India's 'Sankalp Shakti' *

❇️ * Rajya Sabha passes Major Port Authorities Bill 2020 giving greater autonomy to major ports in country *

❇️ * Celebrating STEM Stars: International Day of Women and Girls in Science 2021 *

❇️ * Our doctors, nurses, COVID warriors, Safai Karamcharis, and so many others became manifestations of the divine who strengthened India's fight against the global pandemic: PM *

❇️ * For the latest information on COVID-19 guidelines and Vaccination, Download the MyGov app to get the latest information and updates. *

02/02/2021

A total of 41,20,741 beneficiaries vaccinated through 76,516 sessions, as per the provisional report.

02/02/2021

A total of 41,20,741 beneficiaries vaccinated through 76,516 sessions, as per the provisional report.

1,70,585 beneficiaries were vaccinated through 3,785 sessions till 7 pm today.

29/01/2021

STATESWISE BENEFICIARIEs

Andhra Pradesh1,70,910
Arunachal Pradesh8,651
Assam27,693
Bihar1,06,824
Chandigarh2,764
Chhattisgarh62,110
Delhi48,008
Goa2,882
Gujarat1,54,234
Haryana1,15,968
Himachal Pradesh18,848
Jharkhand24,315
Karnataka2,84,979
Kerala1,06,393
Madhya Pradesh1,67,838
Maharashtra2,18,030
Odisha1,94,058
Punjab50,977
Rajasthan2,44,204
Tamil Nadu88,467
Telangana1,46,665
Uttar Pradesh2,77,608
Uttarakhand19,517
West Bengal1,84,596
Miscellaneous48,401

29/01/2021

Covid vaccination in India:
28 January 2021.

29,28,053 have been vaccinated so far till 6 pm today, of which 5,72,600people were vaccinated on thursday alone, according to the Health Ministry

Nearly 29lakh beneficiaries have been vaccinated since 16 January, when the mass inoculation drive against the novel coronavirus was launched, the Health Ministry said on Wednesday.

22/01/2021

/ vaccination data

22/01/2021

India vaccinates nearly 10.5 lakh (10,43,534) beneficiaries till 6th day of the nationwide COVID19 vaccination drive; more than many other countries.

https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1691127

India has crossed a significant landmark in its collective and resolute fight against the global pan

21/01/2021

https://timesofindia.indiatimes.com/india/covid-vaccine-what-are-common-uncommon-side-effects/articleshow/80340557.cms

India News: On January 16, India launched world's largest vaccination drive against Covid-19, targeting healthcare and frontline workers in the first phase. A tot

21/01/2021

COVISHIELD & COVAXIN

Different Strokes of Immunity

India has formally approved the emergency use of two Covid-9 vaccines as it prepares for one of the world’s biggest inoculation drives. They are

1. COVISHIELD

A. COVISHIELD DEVELOPERS
Covishield has been developed by Oxford University in collaboration with Astrazeneca. Serum India is their manufacturing and trial partner.

B. COVISHIELD MECHANISM
Covishield uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein.

C.COVISHIELD DOSES
The Subject Expert Committee (SEC) has recommended the approval of two full doses of the vaccine administered around 4-6 weeks apart. The vaccine can be stored at temperatures between 2°C and 8°C.

D. COVISHIELD EFFICACY
One dosing regimen shows the vaccine efficacy of 90 per cent when AZD1222 was given as a half dose, followed by a full dose at least a month apart. Second dosing regimen shows 62 per cent efficacy when given two full doses at least a month apart. Combined analysis has an average efficacy of 70 per cent.

2. COVAXIN

A. COVAXIN DEVELOPERS
Covaxin is India’s first indigenous vaccine against Covid-19. It has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology.

B. COVAXIN TYPE
Covaxin is an inactivated vaccine. This destroys the pathogen’s ability to replicate, but keeps it intact so that the immune system can still recognise it and produce an immune response.

C. COVAXIN MECHANISM
Covaxin is based on an inactivated whole virus, having potential to target mutated coronavirus strains including the UK variant. The data generated so far demonstrates a strong immune response (both antibody as well as T cell) and in-vitro viral neutralisation. The ongoing clinical trial is the largest trial on 25,800 subjects, in which already 23,000 volunteers have been enrolled including subjects with comorbid conditions.

D. COVAXIN DOSE
The vaccine will be administered in two doses and stored at 2-8° degrees Celsius.

E. COVAXIN EUA
let it be known that EUA for COVAXIN is differently conditional – in clinical trial mode EUA for COVAXIN is different from COVISHIELD because its use will be in clinical trial mode. All COVAXIN recipients to be tracked,monitored as if they’re in trial as per health ministry.

Anyways
Both vaccines are aimed at training the immune system to recognise the spike protein of the SARS-CoV-2, which causes Covid-19 when it enters a human body. SARS-CoV-2 uses its spike protein to enter a human cell.

We hope that a vaccine-trained immune system generates suitable antibodies in enough numbers to neutralise the coronaviruses.

https://nasirshamas.wordpress.com/2021/01/20/covishield-covaxin/

Dr. Nasir Shamas
20.01.2021

Different Strokes of Immunity                  India has formally approved the emergency use of two Covid-9 vaccines …

21/01/2021

Coronavirus India Live Updates: Total 7.86 lakh healthcare workers got COVID-19 vaccine jabs till Wednesday 6 pm, says Centre

Coronavirus India Live Updates: In total 7.86 lakh healthcare workers have received COVID-19 vaccine jabs till the evening of the fifth day of the immunisation drive, according to a provisional report of the Union Health Ministry on Wednesday, PTI reported. On Wednesday, 1,12,007 beneficiaries were vaccinated till 6 pm across 20 states and Union Territories, it said, adding the final report for the day will be complied by late in the night

18/01/2021

UP hospital worker dies day after coronavirus vaccine shot.

https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/uttar-pradesh-hospital-worker-dies-covishield-covid-vaccine-shot-not-related-to-vaccine-says-cmo-1760104-2021-01-18

A hospital worker in Uttar Pradesh's Moradabad died day after receiving a coronavirus vaccine shot. The district CMO confirmed the death of the hospital worker, saying the reason for his death was heart attack.

17/01/2021

2,24,301 beneficiaries given Covid vaccine so far, 447 cases of adverse events reported.

New Delhi: A total of 2,24,301 beneficiaries have been inoculated with COVID-19 vaccine so far, out of which only 447 adverse events following immunisation (AEFI) were reported, the Union Health Ministry said on day two of the nationwide vaccination drive on Sunday.
Addressing a press briefing, the ministry’s Additional Secretary Manohar Agnani said out of the 447 adverse events following immunisation, only three required hospitalisation.

17/01/2021

https://theprint.in/world/covid-vaccine-deaths-among-elderly-climb-in-norway-raise-concern-over-pfizer-shot/586999/

Pfizer and BioNTech are working with Norway to investigate the deaths. Pfizer said the number of incidents so far is not alarming, and in line with expectations.